Markets CLVT

Why Clarivate Stock Is Skyrocketing Today

Key Points

  • Clarivate beat sales and earnings expectations in Q4.

  • Guidance for this year was also stronger than anticipated.

  • The company is in talks to sell its life sciences and healthcare business.

  • 10 stocks we like better than Clarivate Plc ›

Clarivate (NYSE: CLVT) stock is surging higher in Tuesday's trading. The company's share price was up 31.4% as of 1 p.m. ET. Meanwhile, the S&P 500 was up 0.7%, and the Nasdaq Composite was up 1%.

In addition to bullish momentum for the broader market lifting tech valuations, the stock is getting a big boost from the company's recent earnings report. The analytics specialist published its fourth-quarter results after the market closed yesterday, posting sales and earnings beats and issuing better-than-expected forward guidance.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

A chart line going up.

Image source: Getty Images.

Clarivate's Q4 report delivered wins on multiple fronts

Clarivate recorded non-GAAP (adjusted) earnings of $0.20 per share on sales of $617 million, beating the average analyst estimate's target for a per-share profit of $0.16 on sales of $604.8 million. Revenue was still down roughly 7% year over year, but the decline was much softer than anticipated. Subscription revenues declined to $405.8 million from $407 million but were actually up 1% on an organic basis.

What's next for Clarivate?

Clarivate is targeting free cash flow growth of 10% this year, and it's also forecasting growth between 2% and 3% for annual contract value. Meanwhile, recurring organic revenue is projected to be up between 1% and 2%.

In conjunction with the Q4 report, Clarivate also announced that it was in active discussions to sell its life sciences and healthcare business. The company plans to use the sale of the unit to reduce debt, improve its balance sheet, and pursue expansion in its academia-and-government and intellectual-property categories. Along with better-than-expected guidance for this year, investors seem to be very bullish on the move

Should you buy stock in Clarivate Plc right now?

Before you buy stock in Clarivate Plc, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Clarivate Plc wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $409,970!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,174,241!*

Now, it’s worth noting Stock Advisor’s total average return is 889% — a market-crushing outperformance compared to 192% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of February 24, 2026.

Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

The Motley Fool
Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.
Visit Fool.com for more market news More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available